02.05.2013 Views

Download het volledig rapport (302 p.) - KCE

Download het volledig rapport (302 p.) - KCE

Download het volledig rapport (302 p.) - KCE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>KCE</strong> reports vol. 6A Prenatale zorg 111<br />

What is the impact of primary prevention on the seroconversion rate during pregnancy?<br />

Study Ref Population Intervention Outcomes Results Comments Study<br />

Adler<br />

et al.,<br />

1996<br />

17 Seronegative women<br />

whose child was less<br />

than 36 months of age,<br />

was shedding<br />

cytomegalovirus and was<br />

enrolled in 1 of 15 daycare<br />

centers in<br />

Richmond during 3<br />

years<br />

Non pregnant women were<br />

randomly (each day-care center<br />

was randomly assigned to 1 of 3<br />

groups) assigned to 3 groups.<br />

1. Mothers in the education<br />

group (E) were given<br />

instructions about protective<br />

behaviours and risky behaviours<br />

to avoid<br />

2. The adherence and education<br />

group (A) received in addition<br />

to the procedures for group E,<br />

social reinforcement for<br />

adherence and problem solving<br />

for any perceived problems<br />

with the behavioural<br />

recommendations<br />

3. The control group (C)<br />

received no intervention<br />

A 4 th group of pregnant women<br />

received an intervention<br />

equivalent to that of the<br />

education group<br />

Seroconversion<br />

Time from enrolment to<br />

infection<br />

Seroconversion:<br />

8 of 17 women in group C<br />

4 of 11 women in group E<br />

2 of 8 women in group A<br />

0 of 14 pregnant women (4 th group)<br />

Time from enrolment to infection:<br />

C and E: average time: 4 months<br />

(range: 2-7)<br />

A: 1 seroconverted at 3 months and<br />

1 at 8 months<br />

Small sample size<br />

Intervention and<br />

control group<br />

were not<br />

randomised<br />

EL<br />

type<br />

CSNR 2a<br />

Does the presence of maternal antibodies to CMV reduce the risk of congenital CMV infection in future pregnancies?<br />

Study Ref Populatio Interventio Outcome Results Comment Study EL<br />

n n s<br />

s type<br />

Fowler et al., 2003 18 3461 Newborns Congenit Prevalence of congenital infection in the group of newborns born to<br />

CH 2b<br />

multiparo were al CMV initially seronegative mothers:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!